Therapeutic molecular targets in human chondrosarcoma

International Journal of Experimental Pathology

Volumn 91, Issue 5, 2010, Pages 387-393

  Jamil, Nuor ^a,b   Howie, Sarah ^b   Salter, Donald M ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Apoptosis; Cartilage; Chemotherapy; Chondrocytes; Chondrosarcoma; Radiation

Indexed keywords

2 METHOXYESTRADIOL; BISPHOSPHONIC ACID DERIVATIVE; CASPASE 3; CASPASE 8; DEATH RECEPTOR 4; DEATH RECEPTOR 5; EPIGALLOCATECHIN GALLATE; FAS LIGAND; HISTONE DEACETYLASE INHIBITOR; PARATHYROID HORMONE RELATED PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PHLOROGLUCINOL DERIVATIVE; PIGMENT EPITHELIUM DERIVED FACTOR; PROTEIN BCL 2; PROTEIN BCL XL; SONIC HEDGEHOG PROTEIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER RADIOTHERAPY; CARTILAGE CELL; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROSARCOMA; COMPLEMENT ALTERNATIVE PATHWAY; DNA DAMAGE; HUMAN; HYPOXIA; MOLECULARLY TARGETED THERAPY; PRIORITY JOURNAL; REVIEW;

ANTINEOPLASTIC AGENTS; APOPTOSIS; BONE NEOPLASMS; CHONDROSARCOMA; HUMANS;

EID: 78449290701     PISSN: 09599673     EISSN: 13652613     Source Type: Journal    
DOI: 10.1111/j.1365-2613.2010.00749.x     Document Type: Review

References (54)

1. Bergh P., Gunterberg B., Meis-Kindblom J.M., Kindblom L.G. (2001) Prognostic factors and outcome of pelvic, sacral, and spinal chondrosarcomas: a center-based study of 69 cases. Cancer 91, 1201-1212.
2. Bovee J.V., Hogendoorn P.C., Wunder J.S., Alman B.A. (2010) Cartilage tumours and bone development: molecular pathology and possible therapeutic targets. Nat. Rev. Cancer 10, 481-488.
3. Brenner D. & Mak T.W. (2009) Mitochondrial cell death effectors. Curr. Opin. Cell Biol. 21, 871-877.
4. Bruns J., Elbracht M., Niggemeyer O. (2001) Chondrosarcoma of bone: an oncological and functional follow-up study. Ann. Oncol. 12, 859-864.
5. Burdan F., Szumilo J., Korobowicz A. et al. (2009) Morphology and physiology of the epiphyseal growth plate. Folia Histochem. Cytobiol. 47, 5-16.
6. Butt M.S. & Sultan M.T. (2009) Green tea: nature's defense against malignancies. Crit. Rev. Food Sci. Nutr. 49, 463-473.
7. Chen C., Zhou H., Xu L. et al. (2010) Recombinant human PDCD5 sensitizes chondrosarcomas to cisplatin chemotherapy in vitro and in vivo. Apoptosis 15, 805-813.
8. Clement Y. (2009) Can green tea do that? A literature review of the clinical evidence. Prev. Med. 49, 83-87.
9. Cucchiarini M., Schetting S., Terwilliger E.F., Kohn D., Madry H. (2009) rAAV-mediated overexpression of FGF-2 promotes cell proliferation, survival and alpha-SMA expression in human meniscal lesions. Gene Ther. 16, 1363-1372.
10. Daugaard S., Christensen L.H., Hogdall E. (2009) Markers aiding the diagnosis of chondroid tumors: an immunohistochemical study including osteonectin, bcl-2, cox-2, actin, calponin, D2-40 (podoplanin), mdm-2, CD117 (c-kit), and YKL-40. APMIS 117, 518-525.
11. Dunst J., Stadler P., Becker A. et al. (2003) Tumor volume and tumor hypoxia in head and neck cancers. The amount of the hypoxic volume is important. Strahlenther. Onkol. 179, 521-526.
12. Evans H.L., Ayala A.G., Romsdahl M.M. (1977) Prognostic factors in chondrosarcoma of bone: a clinicopathologic analysis with emphasis on histologic grading. Cancer 40, 818-831.
13. Falschlehner C., Schaefer U., Walczak H. (2009) Following TRAIL's path in the immune system. Immunology 127, 145-154.
14. Fong Y.C., Yang W.H., Hsu S.F. et al. (2007) 2-methoxyestradiol induces apoptosis and cell cycle arrest in human chondrosarcoma cells. J. Orthop. Res. 25, 1106-1114.
15. Furumatsu T., Tsuda M., Yoshida K. et al. (2005) Sox9 and p300 cooperatively regulate chromatin-mediated transcription. J. Biol. Chem. 280, 35203-35208.
16. Garcia-Manero G. & Issa J.P. (2005) Histone deacetylase inhibitors: a review of their clinical status as antineoplastic agents. Cancer Invest. 23, 635-642.
17. Gelderblom H., Hogendoorn P.C., Dijkstra S.D. et al. (2008) The clinical approach towards chondrosarcoma. Oncologist 13, 320-329.
18. Hashimoto Y., Tomiyama T., Yamano Y., Mori H. (2003) Mutation (D472Y) in the type 3 repeat domain of cartilage oligomeric matrix protein affects its early vesicle trafficking in endoplasmic reticulum and induces apoptosis. Am. J. Pathol. 163, 101-110.
19. Herbst R.S., Eckhardt S.G., Kurzrock R. et al. (2010) Phase I dose-escalation study of recombinant human Apo2L/TRAIL, a dual proapoptotic receptor agonist, in patients with advanced cancer. J. Clin. Oncol. 28, 2839-2846.
20. Iguchi H., Onuma E., Sato K., Sato K., Ogata E. (2001) Involvement of parathyroid hormone-related protein in experimental cachexia induced by a human lung cancer-derived cell line established from a bone metastasis specimen. Int. J. Cancer 94, 24-27.
21. Islam S., Islam N., Kermode T. et al. (2000) Involvement of caspase-3 in epigallocatechin-3-gallate-mediated apoptosis of human chondrosarcoma cells. Biochem. Biophys. Res. Commun. 270, 793-797.
22. Johnson S., Tetu B., Ayala A.G., Chawla S.P. (1986) Chondrosarcoma with additional mesenchymal component (dedifferentiated chondrosarcoma). I. A clinicopathologic study of 26 cases. Cancer 58, 278-286.
23. Kersten S., Desvergne B., Wahli W. (2000) Roles of PPARs in health and disease. Nature 405, 421-424.
24. Khan N. & Mukhtar H. (2007) Tea polyphenols for health promotion. Life Sci. 81, 519-533.
25. Kim D.W., Seo S.W., Cho S.K. et al. (2007) Targeting of cell survival genes using small interfering RNAs (siRNAs) enhances radiosensitivity of Grade II chondrosarcoma cells. J. Orthop. Res. 25, 820-828.
26. Kim D.W., Kim K.O., Shin M.J. et al. (2009) siRNA-based targeting of antiapoptotic genes can reverse chemoresistance in P-glycoprotein expressing chondrosarcoma cells. Mol. Cancer 8, 28.
27. Kronenberg H.M. (2006) PTHrP and skeletal development. Ann. N Y Acad. Sci. 1068, 1-13.
28. Kubo T., Shimose S., Matsuo T. et al. (2006) Inhibitory effects of a new bisphosphonate, minodronate, on proliferation and invasion of a variety of malignant bone tumor cells. J. Orthop. Res. 24, 1138-1144.
29. Kubo T., Sugita T., Shimose S., Matsuo T., Arihiro K., Ochi M. (2008) Expression of hypoxia-inducible factor-1alpha and its relationship to tumour angiogenesis and cell proliferation in cartilage tumours. J. Bone Joint Surg. Br. 90, 364-370.
30. Lai T.J., Hsu S.F., Li T.M. et al. (2007) Alendronate inhibits cell invasion and MMP-2 secretion in human chondrosarcoma cell line. Acta Pharmacol. Sin. 28, 1231-1235.
31. Lee F.Y., Mankin H.J., Fondren G. et al. (1999) Chondrosarcoma of bone: an assessment of outcome. J. Bone Joint Surg. Am. 81, 326-338.
32. Lee S.W., Lee H.J., Chung W.T. et al. (2004) TRAIL induces apoptosis of chondrocytes and influences the pathogenesis of experimentally induced rat osteoarthritis. Arthritis Rheum. 50, 534-542.
33. Liu J.F., Yang W.H., Fong Y.C., Kuo S.C., Chang C.S., Tang C.H. (2010) BFPP, a phloroglucinol derivative, induces cell apoptosis in human chondrosarcoma cells through endoplasmic reticulum stress. Biochem. Pharmacol. 79, 1410-1417.
34. Long F., Zhang X.M., Karp S., Yang Y., McMahon A.P. (2001) Genetic manipulation of hedgehog signaling in the endochondral skeleton reveals a direct role in the regulation of chondrocyte proliferation. Development 128, 5099-5108.
35. Miyaji T., Nakase T., Onuma E. et al. (2003) Monoclonal antibody to parathyroid hormone-related protein induces differentiation and apoptosis of chondrosarcoma cells. Cancer Lett. 199, 147-155.
36. Moffitt K.L., Martin S.L., Walker B. (2010) From sentencing to execution - the processes of apoptosis. J. Pharm. Pharmacol. 62, 547-562.
37. Moussavi-Harami F., Mollano A., Martin J.A. et al. (2006) Intrinsic radiation resistance in human chondrosarcoma cells. Biochem. Biophys. Res. Commun. 346, 379-385.
38. Nishida K., Furumatsu T., Takada I. et al. (2002) Inhibition of human chondrosarcoma cell growth via apoptosis by peroxisome proliferator-activated receptor-gamma. Br. J. Cancer 86, 1303-1309.
39. Nishida K., Kunisada T., Shen Z.N., Kadota Y., Hashizume K., Ozaki T. (2008) Chondrosarcoma and peroxisome proliferator-activated receptor. PPAR Res. 2008 Article ID 250568.
40. Oji G.S., Gomez P., Kurriger G., Stevens J., Morcuende J.A. (2007) Indian hedgehog signaling pathway differences between swarm rat chondrosarcoma and native rat chondrocytes. Iowa Orthop. J. 27, 9-16.
41. Quiney C., Billard C., Salanoubat C., Fourneron J.D., Kolb J.P. (2006) Hyperforin, a new lead compound against the progression of cancer and leukemia? Leukemia 20, 1519-1525.
42. Sakimura R., Tanaka K., Yamamoto S. et al. (2007) The effects of histone deacetylase inhibitors on the induction of differentiation in chondrosarcoma cells. Clin. Cancer Res. 13, 275-282.
43. Sibonga J.D., Sommer U., Turner R.T. (2002) Evidence that 2-methoxyestradiol suppresses proliferation and accelerates apoptosis in normal rat growth plate chondrocytes. J. Cancer Res. Clin. Oncol. 128, 477-483.
44. Staals E.L., Bacchini P., Bertoni F. (2006) Dedifferentiated central chondrosarcoma. Cancer 106, 2682-2691.
45. Susa M., Morii T., Yabe H. et al. (2009) Alendronate inhibits growth of high-grade chondrosarcoma cells. Anticancer Res. 29, 1879-1888.
46. Sutherland T.E., Anderson R.L., Hughes R.A. et al. (2007) 2-Methoxyestradiol - a unique blend of activities generating a new class of anti-tumour/anti-inflammatory agents. Drug Discov. Today 12, 577-584.
47. Tang G.Q., Yan T.Q., Guo W. et al. (2010) (-)-Epigallocatechin-3-gallate induces apoptosis and suppresses proliferation by inhibiting the human Indian Hedgehog pathway in human chondrosarcoma cells. J. Cancer Res. Clin. Oncol. 136, 1179-1185.
48. Terek R.M., Schwartz G.K., Devaney K. et al. (1998) Chemotherapy and P-glycoprotein expression in chondrosarcoma. J. Orthop. Res. 16, 585-590.
49. Vincourt J.B., Etienne S., Cottet J. et al. (2010) C-propeptides of procollagens I{alpha}1 and II that differentially accumulate in enchondromas versus chondrosarcomas regulate tumor cell survival and migration. Cancer Res. 70, 4739-4748.
50. Wang Y., Li X., Wang L. et al. (2004) An alternative form of paraptosis-like cell death, triggered by TAJ/TROY and enhanced by PDCD5 overexpression. J. Cell Sci. 117, 1525-1532.
51. Wang Z., Bryan J., Franz C., Havlioglu N., Sandell L.J. (2010) Type IIB procollagen NH2-propeptide, PIIBNP, induces death of tumor cells via interaction with integrins {alpha}v{beta}3 and {alpha}v{beta}5. J. Biol. Chem. 285, 20806-20817.
52. Yamamoto S., Tanaka K., Sakimura R. et al. (2008) Suberoylanilide hydroxamic acid (SAHA) induces apoptosis or autophagy-associated cell death in chondrosarcoma cell lines. Anticancer Res. 28, 1585-1591.
53. Yoshida M., Yasuda T., Hiramitsu T., Ito H., Nakamura T. (2008) Induction of apoptosis by anti-CD44 antibody in human chondrosarcoma cell line SW1353. Biomed. Res. 29, 47-52.
54. Zaichuk T.A., Shroff E.H., Emmanuel R., Filleur S., Nelius T., Volpert O.V. (2004) Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J. Exp. Med. 199, 1513-1522.